GlassScriptPhysician profile
Peter N Eskander
NPI 1932849403
$2,121.70
in general payments reported to CMS, 2019-2025
8 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what 85% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $523 · 2024: $221 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,439 · Travel and Lodging: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,439.28 |
| Travel and Lodging | $682.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,001.64 | 2025 | Na, 1788 |
| Merz North America, INC. | $331.34 | 2023 | Xeomin |
| Medtronic, INC. | $251.98 | 2023-2025 | Fusion, Propel, Straightshot |
| Integra Lifesciences Corporation | $229.57 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Advanced Bionics, LLC | $144.17 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Checkpoint Surgical, INC | $98.69 | 2023 | Checkpoint Stimulators |
| Atos Medical INC | $47.69 | 2024 | Provox Life Home Hme |
| Cochlear Americas | $16.62 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Eskander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.